Madrid, Spain

Nuria Eugenia Campillo Martín

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Consejo Superior De Investigaciones Cientificas, Universidad De La Republica De Uruguay. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nuria Eugenia Campillo Martín. Retrieved from https://idiyas.com/inventor/nuria-eugenia-campillo-martín

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Nuria Eugenia Campillo Martín

Introduction

Nuria Eugenia Campillo Martín is a notable inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of parasitic diseases.

Latest Patents

Her most recent patent is titled "Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide." This invention focuses on compounds derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides, which are intended for use as drugs or pharmaceutical compositions for the treatment of parasitic diseases, with a particular emphasis on Chagas disease.

Career Highlights

Nuria has worked with prestigious institutions such as Universidad de la República de Uruguay and Consejo Superior de Investigaciones Científicas. Her work has been instrumental in advancing research in the pharmaceutical sector.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Juan Antonio Paez Prosper and Ángela Guerra Álvarez. These collaborations have contributed to her success and the impact of her inventions.

Conclusion

Nuria Eugenia Campillo Martín continues to be a prominent figure in the field of pharmaceutical innovation, with her work paving the way for new treatments for parasitic

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…